Key Highlights
- ALAB closed at a new record of $287.48 Wednesday, climbing 18% after Tuesday’s 13% rally
- CEO Jitendra Mohan announced Scorpio X fabric switches will become the company’s largest product by late 2026, targeting a ~$10B market opportunity
- Price targets increased: Evercore ISI to $297, JP Morgan to $280; average analyst target stands at $233.75 with a “Moderate Buy” consensus
- First quarter revenue reached $308.36M, a 93.5% year-over-year jump that exceeded projections; Q2 EPS forecast at $0.68–$0.70
- Shares have climbed 73% year-to-date in 2026 and soared 699% from the $36 IPO price in March 2024
Astera Labs (ALAB) shares closed Wednesday at a historic high of $287.48, marking an impressive 18% single-session rally that followed Tuesday’s 13% climb. Year-to-date, the stock has already posted a 73% gain in 2026.
Astera Labs, Inc. Common Stock, ALAB
The dramatic two-day surge followed enthusiastic management remarks at a J.P. Morgan technology, media and communications conference, growing anticipation around Nvidia’s earnings report, and a wave of upward price target revisions from Wall Street analysts.
CEO Jitendra Mohan delivered remarks at Tuesday’s conference, projecting that the Scorpio product line will emerge as Astera Labs’ primary revenue generator before 2026 ends.
Mohan estimated the addressable market for the Scorpio X fabric switch at approximately $10 billion. He also highlighted optical networking as a strategic frontier the company plans to pursue.
“We are not shy about investing to make sure that we secure our place in the future,” Mohan stated.
The semiconductor firm also emphasized its partnership with Nvidia, particularly around the NVLink Fusion platform serving hyperscale data center clients. Mohan characterized Astera Labs as “the Switzerland of connectivity” — capable of integrating across all leading AI infrastructure platforms.
Wall Street Boosts Price Projections
Evercore ISI increased its price objective to $297 from $215, pointing to growing demand from hyperscale cloud providers. JP Morgan lifted its target to $280 while maintaining an Overweight rating. Morgan Stanley adjusted upward to $240 from $210, also with an Overweight stance.
TD Cowen raised its projection to $225 from $140, though maintained a Hold rating. Rothschild & Co Redburn initiated coverage with a Neutral stance and a $153 price target.
Currently, fifteen analysts assign ALAB a Buy rating while nine recommend Hold. The consensus price target of $233.75 sits below the stock’s current trading level.
Morgan Stanley analyst Joseph Moore described Astera as “one of the best growth rates in our coverage, with multiple product cycles and a very strong position in key AI technology.”
First Quarter Performance Exceeds Forecasts
The recent momentum builds on solid quarterly performance. Astera Labs delivered Q1 earnings per share of $0.61, surpassing the consensus estimate of $0.54. Revenue totaled $308.36 million, exceeding analyst expectations of $292.19 million.
This revenue figure reflects a 93.5% year-over-year expansion. Management issued Q2 EPS guidance of $0.68–$0.70, significantly ahead of Wall Street’s projections.
Morgan Stanley identified Scorpio as “the primary driver of upside” following the first quarter report.
Regarding institutional positioning, Csenge Advisory Group initiated a position valued at roughly $1.3 million during Q4. Multiple other institutional investors expanded their holdings.
Insider trading activity shows a contrasting pattern. Over the previous 90 days, company insiders divested 1.64 million shares valued at approximately $288.7 million. General Counsel Philip Mazzara sold 14,076 shares on May 18 at $231.78 per share. The transaction was linked to tax requirements associated with equity compensation vesting.
The company currently commands a market capitalization of $49.28 billion with a price-to-earnings ratio of 194.24. Since debuting at $36 during its March 2024 IPO, ALAB has surged 699%.


